NASDAQ

Regeneron Pharmaceuticals, Inc. (REGN)

♥ 646 Thanks from members

Live price chart, market sentiment, and community perspectives for Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Dr. Leonard SchleiferFounder: Dr. George YancopoulosLeadership: Dr. Leonard Schleifer (CEO)Leadership: Dr. George Yancopoulos (Chief Scientific Officer)Holder: Capital Research and ManagementHolder: Vanguard GroupHolder: BlackRock Inc.EyleaDupixentLibtayoPraluent#REGN stock#Regeneron#biotech giant#Dupixent#monoclonal antibodies